Genes2Me Pvt. Ltd. launched a Real-Time PCR-based kit for quick detection of the monkeypox virus with a fast turnaround time of less than 50 minutes. The kit is available in both standard versions for any commonly available RT-PCR instruments and point-of-care format on the Genes2Me Rapi-Q HT device, according to the diagnostic company. The point-of-care solution is designed to be used for screening at multiple sites, including hospitals, airports, diagnostic labs, health camps, etc.

Mr. Neeraj Gupta, CEO, and Founder of Genes2Me stated that the kit was designed to give an accurate result in less than 50 minutes. He also added that the company can manufacture 5 million test kits in a week. However, the capacity can be scaled up to 2 million kits a day with the added demand.

The World Health Organization declared the monkeypox outbreak a "Public Health Emergency of International Concern" (PHEIC) after 16000 cases were reported from 75 countries and territories. Mr. Gupta added that the scientists from Genes2Me have developed a ‘POX-Q Multiplexed RT-PCR kit’ for the detection of the monkeypox virus. The kit can also differentiate the monkeypox virus from the Varicella-Zoster virus in a single-tube multiplex reaction format. The kit, developed for Research Use Only (RUO), is the first of its kind to be made in India. The kit is based on the gold standard TaqMan chemistry-based RT PCR method.